These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 990157
1. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension. Ronne-Rasmussen JO, Andersen GS, Jensen NB, Andersson E. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157 [Abstract] [Full Text] [Related]
3. Double-blind trial of labetalol. Kane J, Gregg I, Richards DA. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329 [Abstract] [Full Text] [Related]
4. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Koch G. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950 [Abstract] [Full Text] [Related]
6. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Trust PM, Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333 [Abstract] [Full Text] [Related]
15. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension. la Cour Petersen E, Kristensen BO. Postgrad Med J; 1980 Aug; 56 Suppl 2():60-4. PubMed ID: 7433345 [Abstract] [Full Text] [Related]
16. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)]. Zech P, Pozet N, Sassard J, Vincent M. Nouv Presse Med; 1980 Mar 29; 9(15):1087-90. PubMed ID: 7008020 [Abstract] [Full Text] [Related]